World Health Organization site
Skip Navigation Links

Main
Note: This record shows only the 20 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: REBEC
Last refreshed on: 29 April 2013
Main ID:  RBR-9vw39v
Date of registration: 28/06/2012
Primary sponsor: Universidade Estadual de Campinas (UNICAMP) - Campinas, SP, Brazil
Public title: Treatment of female urinary incontinence with electrical stimulation of vaginal muscle and evaluation of vaginal pH
Scientific title: Stress urinary incontinence: treatment with intravaginal electric stimulation and vaginal pH evaluation
Date of first enrolment: 01/01/2011
Target sample size: 78
Recruitment status: recruitment completed
URL:  http://www.ensaiosclinicos.gov.br/rg/RBR-9vw39v/
Study type: 
Study design:  clinical trial single arm  
Countries of recruitment
Brazil
Contacts
Name: Mariana   Tirolli Rett
Address:  Rua Claudio Batista s/n 49.060-100 Aracaju-SE Brazil
Telephone: +55(79)81043005
Email: marianatrb@gmail.com
Affiliation:  Universidade Federal de Sergipe (UFS)
Name: Mariana   Tirolli Rett
Address:  Rua Claudio Batista s/n 49.060-100 Aracaju-SE Brazil
Telephone: +55(79)81043005
Email: marianatrb@gmail.com
Affiliation:  Universidade Federal de Sergipe (UFS)
Key inclusion & exclusion criteria
Inclusion criteria: women with clinical symptoms of stress urinary incontinence and mixes urinary incontinence
Exclusion criteria: Women with the presence of an intrauterine dispositive, heart pacemaker, use of hormonal therapy, use of antibiotics, use of an intravaginal drug, urinary tract infection for less than two weeks, vaginal infection, severe pelvic organ prolapse (grade III), pregnancy, postpartum, leucorrhea, itching, pelvic pain, vulvar irritation, and/or other vaginal symptoms that could interfere with the results,urethral obstructions, neurogenic detrusor overactivity and detrusor hypocontractility

Age minimum: 18
Age maximum: 75
Gender: F
Health Condition(s) or Problem(s) studied
urinary incontinence,vaginal infection
C12.777.934.852
C01.252.954
Intervention(s)
At the initial visit, the subjects individually received verbal information about pelvic floor anatomy, muscle localization and function. There were 2 sessions per week for 4 weeks giving a total of 8 sessions of . The QUARK Dualpex 961™ device with a cylindrical shaped electrode surrounded by four metal rings was used for intravaginal electrical stimulation (IVES).The IVES parameters were: a 35 Hertz fixed frequency, a 500 microsecond pulse, 20 minute of duration and current intensity varying according to patient tolerance. Each individual patient had their own electrode throughout the study.
Primary Outcome(s)
Changes of the vaginal microflora after intravaginal electrical stimulation: evaluated by bacterioscopy
Secondary Outcome(s)
Changes of pH after was measured before and after intravaginal electrical stimulation: evaluated by pH strip (values from 4 to 7)
Quality of life after urinary incontinence treatment: evaluated by specific questionnaire (International Consultation on Incontinence Questionnaire-Short Form - ICIQ-SF)
Secondary ID(s)
0059.0.213.000-05
0281.0.146.000-06
Source(s) of Monetary Support
PUC Minas - Betim, MG, Brazil
Universidade Estadual de Campinas (UNICAMP) - Campinas, SP, Brazil
Secondary Sponsor(s)
PUC Minas - Betim, MG, Brazil
Universidade Federal de Sergipe (UFS) - Aracaju, SE, Brazil
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.1 - Version history